Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.
No association between chronic cerebrospinal venous insufficiency and pediatric-onset multiple sclerosis.
Fatal Neuroinflammation in a Case of Multiple Sclerosis with Anti-Natalizumab Antibodies.
Disability weight for each level of the Expanded Disability Status Scale in multiple sclerosis.
Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination.
Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS.
Corpus Callosum Atrophy - A Simple Predictor of Multiple Sclerosis Progression: A Longitudinal 9-Year Study.
T cell-intrinsic ASC critically promotes TH17-mediated experimental autoimmune encephalomyelitis.
The role of growth factors as a therapeutic approach to demyelinating disease.
Is it time for a new global classification of multiple sclerosis?
Elevated Expression of the Cerebrospinal Fluid Disease Markers Chromogranin A and Clusterin in Astrocytes of Multiple Sclerosis White Matter Lesions.
Current and future drugs for treatment of MS-associated bladder dysfunction.
Building a better sphingosine kinase-1 inhibitor.
Symptom overlap in anxiety and multiple sclerosis.
Novartis updates US label on Gilenya® following discussions with the FDA
No Regional Gray Matter Atrophy Differences between Pediatric- and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates.
Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison.
Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.
Neuronal antigens recognized by cerebrospinal fluid IgM in multiple sclerosis.
Longitudinally extensive transverse myelitis with anti-NMDA receptor antibodies during a systemic lupus erythematosus flare-up.
Genzyme to Resubmit LemtradaTM Application for FDA Review
[Multiple sclerosis: new approaches to comprehensive treatment and rehabilitation using the method of reflexology].
A Multidimensional Computerized Adaptive Short-Form Quality of Life Questionnaire Developed and Validated for Multiple Sclerosis: The MusiQoL-MCAT.
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.
Pages
« first
‹ previous
…
125
126
127
128
129
130
131
132
133
…
next ›
last »